Medicinova (MNOV) Receivables - Other (2010)
Medicinova (MNOV) posted quarterly Receivables - Other of $47.0 for Q4 2010.
Medicinova (MNOV) Receivables - Other (2010) Analysis & Trends
Medicinova (MNOV) has reported Receivables - Other for 1 consecutive years, with $47.0 the latest figure, recorded in Q4 2010.
- In Q4 2010, Receivables - Other changed N/A year-over-year to $47.0; the TTM figure through Dec 2010 stood at $47.0 (changed N/A YoY), while the FY2010 annual figure was $47.0, changed N/A from the prior year.
- Receivables - Other was little changed at $47.0 in Q4 2010 per MNOV's latest filing.
- Across five years, Receivables - Other topped out at $47.0 in Q4 2010 and bottomed at $47.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - |
| 10 | Medicinova | 68.66 Mn | 68.66 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 47.00 |
| Dec 31, 2010 | 47.00 |